Cargando…
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
BACKGROUND: World Health Organization expert groups recommended mortality trials of four repurposed antiviral drugs — remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a — in patients hospitalized with coronavirus disease 2019 (Covid-19). METHODS: We randomly assigned inpatients with C...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Massachusetts Medical Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727327/ https://www.ncbi.nlm.nih.gov/pubmed/33264556 http://dx.doi.org/10.1056/NEJMoa2023184 |
Ejemplares similares
-
Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system
por: Punekar, Madhura, et al.
Publicado: (2022) -
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
Publicado: (2022) -
Interim Guidelines on Antiviral Therapy for COVID-19
por: Kim, Sun Bean, et al.
Publicado: (2020) -
Efficacy of repurposed antiviral drugs: Lessons from COVID-19
por: Martinez, Miguel Angel
Publicado: (2022) -
Solidarity and collectivism in the context of COVID-19
por: Flynn, Angela V
Publicado: (2022)